Skip to main content.
Polar NanoPharma
Startup
-
Location
Hall 8.1 - 4YFN Stand 8.1A60
Information
Polar NanoPharma is a DeepTech oncology company developing a scalable nanoparticle delivery platform that makes cancer drugs safer and more effective. Our proprietary polymer technology enables precise tumor-targeted release of small molecules and biologics, significantly improving therapeutic index while reducing systemic toxicity. With a pipeline-in-a-platform model, strong IP, and a clear licensing and M&A pathway, we are positioned to unlock high-value oncology markets, including triple-negative breast cancer, lung cancer, and preventive immunotherapy for Lynch syndrome in collaboration with Hospital Clínic.
Key Information
-
Pre-Seed
Growth Stage
-
CountrySpain
-
Founding Year2024